The store will not work correctly when cookies are disabled.
3-(4-Methoxyphenyl)-1H-Indazole-5-Carboxamide
ID: ALA3986715
PubChem CID: 22479950
Max Phase: Preclinical
Molecular Formula: C15H13N3O2
Molecular Weight: 267.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2n[nH]c3ccc(C(N)=O)cc23)cc1
Standard InChI: InChI=1S/C15H13N3O2/c1-20-11-5-2-9(3-6-11)14-12-8-10(15(16)19)4-7-13(12)17-18-14/h2-8H,1H3,(H2,16,19)(H,17,18)
Standard InChI Key: UDJDNKGGBIIFJV-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
14.6502 -7.4702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6491 -8.2898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3571 -8.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3554 -7.0614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0640 -7.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0688 -8.2853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8488 -8.5337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3262 -7.8686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8411 -7.2092 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1045 -9.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5595 -9.9152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8160 -10.6903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6171 -10.8562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1612 -10.2408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9018 -9.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8751 -11.6316 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9411 -8.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2337 -8.2887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9404 -9.5150 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6757 -11.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
13 16 1 0
2 17 1 0
17 18 1 0
17 19 2 0
16 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 267.29 | Molecular Weight (Monoisotopic): 267.1008 | AlogP: 2.34 | #Rotatable Bonds: 3 |
Polar Surface Area: 81.00 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.65 | CX Basic pKa: 1.58 | CX LogP: 2.02 | CX LogD: 2.02 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -1.10 |
References
1. (2002) Indazole derivatives as JNK inhibitors and compositions and methods related thereto, |